Type 1 diabetes

The Predictive Ability of C-Peptide in Distinguishing Type 1 Diabetes From Type 2 Diabetes: A Systematic Review and Meta-Analysis

Endocr PractPublished Systematic review and meta-analysis

Authors' conclusion

Plasma C-peptide levels are highly associated and predictive of the accurate classification and diagnosis of diabetes types. A plasma C-peptide cutoff of ≤0.20 mmol/L is indicative of T1D and of ≥0.30 mmol/L in the fasting or random state is indicative of T2D.

Study context

Population
Studies of plasma C-peptide in T1D and T2D; PubMed, MEDLINE, EMBASE and Scopus, citations 1942 to 2021; studies varied by race, age, time and proportion of individuals12 articles
Comparison
C-peptide levels in T1D vs T2D
Outcome
C-peptide levels
Methodological detailsPRISMA checklist, fixed- and random-effect models, 23,658 abstracts screened, 46 full texts reviewed
  • PRISMA checklist
  • Fixed- and random-effect models
  • 23,658 abstracts screened, 46 full texts reviewed

Pooled result

As reported in the abstract

Predictive ability of C-peptide in discriminating T1D from T2D

Lower concentrations and fasting or random plasma C-peptide cutoff indicative of T1D

<0.20 nmol/L

Heterogeneity I2

98.8%

Original publication

The Predictive Ability of C-Peptide in Distinguishing Type 1 Diabetes From Type 2 Diabetes: A Systematic Review and Meta-Analysis. Endocr Pract. Published 11 January 2023. doi:10.1016/j.eprac.2023.01.004

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.